Teva Pharmaceutical Dividend yield

 Price  32.99
 Dividend  0.00
 Earnings  3.55
 Cash-flow  2.32
 Book value  29.99
 Equity  28.86

Teva Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Teva Pharmaceutical is a company from Israel, and his stocks are publicly traded.

Teva Pharmaceutical paid a total dividend of 0 million ILS last year, for a market value of 36,619 millions (Market Cap 3,289,561 millions). Dividend per share of Teva Pharmaceutical is 0.00 ILS, and his stock market price 32.99 ILS.

According to the chart below where dividend yield is displayed, Teva Pharmaceutical, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Israel, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Teva Pharmaceutical might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Teva Pharmaceutical dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Israel.

Dividend yield of Teva Pharmaceutical

Teva Pharmaceutical Dividend Payout

About the ability of Teva Pharmaceutical to maintain his current dividend of ILS 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Teva Pharmaceutical payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Teva Pharmaceutical, compared againt world market average, Israel companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Teva Pharmaceutical payout

Teva Pharmaceutical Dividend History

Year Yield  ILS  Paypout  Shares* 

*In millions

Teva Pharmaceutical Stock performance

Finally, last moth Teva Pharmaceutical showed a return of 11.80% compared to a worldwide -2.30% average, and a -1.20% of Health Care firms. Over the last year, the company obtained a 22.40% versus a worldwide performance of a -5.85%. More detailed information can be seen in the following graph for Israel and Pharmaceuticals and Biotechnology firms.

Teva Pharmaceutical stock and market return